News

Published on 9 Mar 2022 on Zacks via Yahoo Finance

Are Options Traders Betting on a Big Move in Arena (ARNA) Stock?


Article preview image

Investors in Arena Pharmaceuticals, Inc. ARNA need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 15, 2022 $90.00 Put had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT)

Merger activity declined last week with three new deals announced and five deals completed. Two o...

Benzinga 14 Mar 2022

Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price

This post contains sponsored advertising content. This content is for informational purposes only...

Benzinga 10 Mar 2022

Are Options Traders Betting on a Big Move in Arena (ARNA) Stock?

Investors in Arena Pharmaceuticals, Inc. ARNA need to pay close attention to the stock based on m...

Zacks via Yahoo Finance 9 Mar 2022

Arena Pharma gains after report Pfizer deal will clear without HSR second request

Arena Pharmaceuticals (ARNA) rose 3.5% in after hours trading on a report that it's planned sale ...

Seeking Alpha 7 Mar 2022

John Dorfman: Why I think George Soros is wrong about Rivian

Dozens of car companies sprung up, and some were hot stocks at the time. Rivian could share the f...

Pittsburgh Tribune-Review 28 Feb 2022

Arena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in Focus

Arena Pharmaceuticals, Inc. ARNA incurred a loss of $2.54 per share for fourth-quarter 2021, wide...

Zacks via Yahoo Finance 24 Feb 2022

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical...

Here's a roundup of top developments in the biotech space over the last 24 hours. Kodiak's Wet AM...

Benzinga 23 Feb 2022

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead...

Biotech stock extended lower for a second straight week as risk aversion continued to pressure st...

Benzinga 20 Feb 2022

Deals Are Booming, but Antitrust Scrutiny Has Deal Traders Worried

Merger targets Activision Blizzard Spirit Airlines and Zynga are trading well below their...

The Wall Street Journal 12 Feb 2022

Despite High Forecasts for 202

PFE, Financial) past the $100 billion revenue mark this year, nearly double what the pharma giant...

Guru Focus 12 Feb 2022